Clinical Study Sites Struggle to Manage Responses to Ad Campaigns

May 31, 2018

An overwhelming response to a media campaign can paralyze a study site. That’s because too many potential enrollees can be as bad as too few.

Many sites are ill-equipped to handle the volume of referrals generated by a successful campaign. Referrals don’t get processed--or are processed incorrectly. Subjects are lost, and the trial is delayed.

Delays add costs: $1.7 million is lost for every day a study is postponed.1 Moreover, 68 percent of sites fail to meet their projected enrollment targets.

Even worse, 20-25 percent of all clinical studies close because they fail to meet enrollment targets.3

It all begins with the ad campaign.

Download this whitepaper to learn more about ad campaigns.

Previous Flipbook
Subject Recruitment Materials: Understanding the Requirements for IRB Review
Subject Recruitment Materials: Understanding the Requirements for IRB Review

Often, the only way for potential research subjects to learn about a clinical trial is through recruitment ...

Next Flipbook
How Roche Optimized its Global Safety Reporting Process for Clinical Trials
How Roche Optimized its Global Safety Reporting Process for Clinical Trials

Roche recognized several major challenges that its CTSP 2.0 system needed to address.